2022 World Conference on Lung Cancer (ePosters)-EP02.01-014. Prognostic Classification of Early-Stage Lung Cancer Using Preoperative Prealbumin and D-dimer Levels

EP02.01-014. Prognostic Classification of Early-Stage Lung Cancer Using Preoperative Prealbumin and D-dimer Levels

Pdf Summary

A study conducted by researchers in Japan has identified preoperative prealbumin and D-dimer levels as potential prognostic markers for early-stage lung cancer. The study aimed to determine which blood test markers were strongly associated with long-term prognosis in patients with early-stage lung cancer.<br /><br />The researchers found that the significant difference in overall survival (OS) and recurrence-free survival (RFS) after surgery was linked to the levels of prealbumin and D-dimer. Multivariable analysis showed that patients in groups B and C had poorer OS and RFS than other groups.<br /><br />Abnormal prealbumin and D-dimer levels were identified as independent factors associated with OS and RFS. The study also found that patients in group C were older, had lower lung capacity, more comorbidities, and larger tumor sizes.<br /><br />This research adds to the understanding of prognostic factors in early-stage lung cancer and suggests that preoperative blood tests for prealbumin and D-dimer levels could aid in the prognostic classification and management of patients with this disease. Further studies are needed to validate these findings and determine the clinical implications of these prognostic markers.

Asset Subtitle

Takashi Yamamichi

Meta Tag

Speaker Takashi Yamamichi

Topic Early Stage Non-small Cell Lung Cancer - Biomarkers

Keywords

study

preoperative prealbumin

D-dimer levels

prognostic markers

early-stage lung cancer

blood test markers

long-term prognosis

overall survival

recurrence-free survival

independent factors